Dyne Therapeutics, Inc.

Biotechnology • Healthcare • Waltham, MA, United States • DYN (NMS)

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

781 786 8230 1560 Trapelo Road, Waltham, MA 02451, United States

Stock Performance (90 Days)

Data through Dec 30, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Why Dyne Therapeutics Stock Was Crushing it This Week - MSN

MSN • Dec 29

Why Dyne Therapeutics Stock Tanked on Tuesday - The Motley Fool

The Motley Fool • Dec 9

First Week of February 2026 Options Trading For Dyne Therapeutics (DYN) - Nasdaq

Nasdaq • Dec 29

WilmerHale Advises Dyne Therapeutics on its $402.5 Million Public Offering of Common Stock - WilmerHale

WilmerHale • Dec 12

Why Analysts See a Huge Upside for Dyne Therapeutics (DYN) - Yahoo Finance

Yahoo Finance • Dec 22

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Dyne Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Dyne Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Dyne Therapeutics, Inc. have?

Dyne Therapeutics, Inc. has approximately 240 employees.

What industry is Dyne Therapeutics, Inc. in?

Dyne Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Dyne Therapeutics, Inc. a publicly traded company?

Yes, Dyne Therapeutics, Inc. is publicly traded under the ticker symbol DYN on the NMS. The company has a market capitalization of approximately $3.13 billion.

Where is Dyne Therapeutics, Inc. headquartered?

Dyne Therapeutics, Inc. is headquartered in Waltham, MA, United States at 1560 Trapelo Road, Waltham, MA 02451, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.